Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis

Publisher: Karger

E-ISSN: 1421-9662|119|3|133-141

ISSN: 0001-5792

Source: Acta Haematologica, Vol.119, Iss.3, 2008-04, pp. : 133-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract